Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Letter to the Editor: Comments on July’s Ethics Forum

Staff  |  Issue: September 2010  |  September 1, 2010

Comments on July’s Ethics Forum

Let me preface this by first applauding all of you for the creation of the ethics column and the selection of the first case, as it so adequately reflects the current socioeconomic climate within which we practice.

In regards to the case in which the patient stated that she could not afford the visit nor the labs required for her methotrexate to be refilled, I encounter this problem almost biweekly in our small Reno rheumatology practice. I first tell the patient why I can’t just prescribe the medicine. (Remember, most patients they think this simply entails the writing of a prescription without any liability or actual concern for patient safety.) After telling the patient what I can’t do, I then utilize a common strategy in customer service, which is to tell the patient what I can and am willing to do for him or her. I do ask that the patient be seen to discuss the matter further. If there is no insurance, a practice can offer a discount for not needing to bill the patient. This is not incongruent with commercial insurance or governmental program contracts, because your “discount” is not for the medical service, but rather for not having to bill the patient, provided they pay the discounted amount at the time of service. Of course, you must be willing to offer a similar discount to other patients in the same situation to avoid being accused of “unfair business practices.” This is not the same as discounting the fee for a patient with insurance, who has a large deductible or copayment, which would likely be a violation of the provider’s agreement with the insurer. Of course, each provider would have to verify individual state laws.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

When I see the patient, I advise him or her of why I can’t simply provide the prescription. I am held to certain guidelines. These guidelines have been established to provide adequate patient safety. Good care is good care, regardless of ability to pay. However, there is a difference between “good” care and “ideal” care, and I am willing to provide “good” care if the patient is also willing to settle for this. I am not willing to provide “unsafe” care. If the patient suffers a complication, in this case due to methotrexate toxicity, I am not held to a lower standard of care because of the patient’s inability to pay. Of course, the patient will insist that he or she would never sue me, but I remind them that their loved ones or the state can sue me on their behalf, and I will have to live with the effects of my decision. My failure to follow minimum standards is not only malpractice, but unethical. It is one thing when a patient decides, after informed consent, to decline treatment because of the inability to afford such treatment, and the patient suffers a preventable complication as a result of omission of such treatment; it is another matter when the patient suffers a preventable complication as a result of a treatment which I helped by my provision of treatment.

Page: 1 2 3 | Single Page
Share: 

Filed under:EthicsProfessional Topics Tagged with:EthicsHealth InsuranceMethotrexateRheumatoid arthritis

Related Articles
    The Why & What of the ACR's Clinical Practice Guidelines

    The Why & What of the ACR’s Clinical Practice Guidelines

    February 18, 2018

    With the support of its membership, the ACR publishes clinical practice guidelines in multiple disease areas based on the best available clinical and scientific data. These aim to support health professionals treating rheumatology patients to give the best possible care. Like any set of medical guidelines, ACR guidelines are based on evidence of several different…

    Monkey Business Images/shutterstock.com

    Assessing Autoimmune Disease Symptoms in Silicone Breast Implant Recipients

    December 15, 2016

    My nurse, Joanne, took me aside before I began my next consult. “Room No. 5, breast implant patient. Her lawyer organized the records.” She handed me a hefty three-ring notebook organized by color-coded tabs. “Her attorney called just now,” Joanne raised an eyebrow, “and told me to tell you that, to save time, he highlighted…

    On Boulders & Other Projects

    December 18, 2019

    The year is drawing to a close, and I have not been forced to release a statement that I am leaving The Rheumatologist “to spend more time with my family.” Once again, improbably, I have made it to the finish line. Given that, now seems to be a good time to reflect, and to give…

    Ethics Forum: Ethics of Infusions in the Face of A Professional Conflict

    August 1, 2013

    An infusion prescription ordered by a rheumatologist, but changed by a hematologist, raises dilemmas concerning a patient’s continuity of care

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences